EPIMINDER
LIVE

Serial Number

79294247

Owner

Epiminder Limited

Attorney

Anne Wang

Filing Date

Aug 11, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EPIMINDER Trademark

Serial Number: 79294247 • Registration: 6564675

EPIMINDER is a trademark filed by Epiminder Limited on August 11, 2020. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Epiminder Limited (5 trademarks)

Office 210/211,

Entity Type: 98

Epi-Minder Pty Ltd (5 trademarks)

Office 210/211, West Podium, Mezzanine 2,

Entity Type: 98

Trademark Details

Filing Date

August 11, 2020

Registration Date

November 23, 2021

Published for Opposition

September 7, 2021

Goods & Services

Medical apparatus and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; electronic medical apparatus for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical diagnostic devices and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical devices and instruments for monitoring and treating health and medical conditions, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical implants made of artificial materials for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; wearable medical devices for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; apparatus for use in the diagnosis, monitoring and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; sensors being measurement apparatus for medical use, namely, the monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics

Medical research in the field of neurological conditions and central nervous system disorders; medical research in the field of epilepsy; technological research and design in the field of medical devices, apparatus and instruments; technological research and design of computer hardware, firmware and software for use in the medical field; software as a service (SAAS) services featuring software for use in database management and signal analysis for use in the medical field; platforms as a service (PAAS) services featuring computer software platforms for use in database management and signal analysis for use in the medical field; installation, maintenance and repair of computer firmware and computer software for use in the medical field

Collection of medical data into computer databases for business purposes; compilation of medical reports into computer databases for business purposes; data base management, being medical data; data management consultancy, being medical data

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 22, 2026 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 31, 2025 ADCH
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 31, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 31, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 31, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 31, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 31, 2024 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 6, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 12, 2022 FICS
FINAL DISPOSITION PROCESSED
May 11, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 23, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 23, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 7, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Sep 5, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 18, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 18, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 23, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 23, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 23, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 23, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 17, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2021 COAR
REFUSAL PROCESSED BY IB
Jan 24, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 31, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 31, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 16, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 15, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 2, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 25, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 24, 2020 REPR